C
Circular Genomics
Developer of circular RNA-based precision medicine tools, data and diagnostics for precision neurology and psychiatry
At a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- San Diego, United States
- Employees
- 19
- Open positions
- 2
- Dealroom signal
- 80.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Precision Medicine, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2025 | $15M | $60M | Alzheimer's Drug Discovery Foundation · Healthcare Innovation Pitch · Mountain Group Partners | ↗ |
| EARLY VC✓Equity / VC | Jul 2025 | $250K | $42M | Diagnostics Accelerator | ↗ |
Growth signals
Latest recorded traffic for Circular Genomics is 3K monthly website visits, down 41.2% over the last three months. Circular Genomics's team grew 18.8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Cottonwood Technology Fund
Tramway Venture Partners
Mountain Group Partners
UNM Rainforest Innovations
Diagnostics Accelerator
Alzheimer's Drug Discovery Foundation
Healthcare Innovation Pitch
Other known investors1 additional known investor
University of New Mexico
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Circular Genomics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Circular Genomics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







